SA
Sign upLog In
RGDXQ

Response Genetics, Inc. specializes in molecular diagnostics for cancer, focusing on personalized medicine through genetic testing. Its competitive position is bolstered by proprietary technology for analyzing tumor samples, primarily serving oncologists and hospitals in the U.S.

HealthcareMedical - Diagnostics & Researchlow - The company has high fixed costs associated with laboratory operations and technology investments, which limits its ability to leverage revenue growth into profitability.

Business Overview

01Molecular diagnostic testing services - 100%

Response Genetics generates revenue primarily through its molecular diagnostic testing services, which provide oncologists with critical genetic information to guide treatment decisions. The company benefits from a growing demand for personalized medicine, leveraging its proprietary testing technology to differentiate itself in a competitive market.

What Moves the Stock

Adoption rates of personalized medicine in oncology

Regulatory approvals for new diagnostic tests

Partnerships with healthcare providers and pharmaceutical companies

Watch on Earnings
Revenue growth from new test offeringsGross margin improvementsCustomer acquisition rates

Risk Factors

Technological disruption from new diagnostic methods

Regulatory changes affecting testing protocols

Emergence of new competitors with advanced genetic testing technologies

Price competition from larger diagnostic firms

Liquidity risks due to negative cash flow

Potential for increased operational costs without corresponding revenue growth

StructuralCompetitiveBalance Sheet

Macro Sensitivity

Economic Cycle

moderate - The demand for diagnostic services can be influenced by healthcare spending, which is correlated with GDP growth.

Interest Rates

Moderate sensitivity as rising interest rates could increase financing costs for operational expenditures, although the company is not heavily reliant on debt.

Credit

minimal - The company has a low debt-to-equity ratio, indicating limited reliance on credit.

Live Conditions
Dow Jones FuturesS&P 500 FuturesRussell 2000 Futures

Profile

growth - Investors looking for companies in the expanding field of personalized medicine may find RGDXQ appealing.

high - The stock may exhibit high volatility due to its small market cap and dependence on regulatory outcomes.

Key Metrics to Watch
Adoption rates of genetic testing in oncology
Regulatory approval timelines for new tests
Market share in the molecular diagnostics sector

Explore More

Stock Comparison

Compare equities side by side

52-Week Highs Breakout

Stocks breaking to new annual highs

52-Week Lows Oversold

S&P 500 oversold value screener

Trending Momentum

Relative strength momentum leaders

Earnings Calendar

Upcoming earnings dates & reports

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.